Editorial

November 30, 2024


Editorial for JUO 2024 Vol. 22 No. 3 - Rethinking Urologic Oncology Surgery
Cheol Kwak
J Urol Oncol. 2024;22(3):185-187.

Original Article

November 30, 2024


Early Experience of the Single-Port Robotic Transvesical Radical Prostatectomy: Case Series
Jae Hoon Chung, Hwanik Kim, Woo Jin Bang, et al.
J Urol Oncol. 2024;22(3):188-195.

Original Article

November 30, 2024


Simultaneous Prostate Target Biopsy Integrated With Radical Prostatectomy: A Pilot Study Omitting Preoperative Systematic Biopsy
Tae Young Park, Jae Young Hwang, Seong Woo Yun, et al.
J Urol Oncol. 2024;22(3):196-200.

Original Article

November 30, 2024


A Machine Learning Model for Prostate Cancer Prediction in Korean Men
Sukjung Choi, Beomgi So, Shane Oh, et al.
J Urol Oncol. 2024;22(3):201-210.

Original Article

November 30, 2024


Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Abiraterone Clinical Trials
Matthew Rashid, Eli Oldham, Griffin K. Hughes, et al.
J Urol Oncol. 2024;22(3):211-223.

Brief Report

November 30, 2024


The Current Role of Metastasis-Directed Therapy for Oligometastatic Renal Cell Carcinoma
Hyung Joon Kim
J Urol Oncol. 2024;22(3):224-227.

Invited Review

November 30, 2024


Exploring the Evolving Role of Metastasectomy in Advanced Renal Cell Carcinoma
Jongkyou Kwon, Sungun Bang, Kang Su Cho
J Urol Oncol. 2024;22(3):228-236.

Original Article

November 30, 2024


Clinical Application of Artificial Intelligence-Based Computed Tomography Analysis of Myosteatosis in Localized Renal Cell Carcinoma
Byeong Jin Kang, Kyung Hwan Kim, Seung Baek Hong, et al.
J Urol Oncol. 2024;22(3):237-245.

Invited Review

November 30, 2024


The Emerging Treatment of BCG (Bacillus Calmette-Guérin)-Unresponsive Non–Muscle-Invasive Bladder Cancer
Jong Ho Park, Jong Jin Oh
J Urol Oncol. 2024;22(3):246-255.

Invited Review

November 30, 2024


Trimodal Therapy in the Treatment of Muscle-Invasive Bladder Cancer
Yongsoo Jo, Hyeong Dong Yuk
J Urol Oncol. 2024;22(3):256-267.

Review Article

November 30, 2024


Artificial Intelligence: The Latest Advances in the Diagnosis of Bladder Cancer
Satyendra Singh, Ram Mohan Shukla
J Urol Oncol. 2024;22(3):268-280.

Correction

September 11, 2024


Correction: Addendum of Informed Consent Statements
J Urol Oncol. 2024;22(3):281-281.

Expression of Concern

November 30, 2024


Expression of Concern: Rare Ewingoid Dedifferentiated Liposarcoma of the Spermatic Cord Causing Testicular Artery Compression: A Case Report
J Urol Oncol. 2024;22(3):282-282.
Complex Epidemiology of Prostate Cancer in Asian Countries  (5,374 times)
Kagenori Ito, Takahiro Kimura
J Urol Oncol. 2023;21(1):5-13.

Review Article

Mar 31, 2023

Current Update on Prostate Cancer Immunotherapy  (3,666 times)
Juliana E. Kim, Kunwoo Lee, Isaac Yi Kim
J Urol Oncol. 2023;21(1):14-22.

Review Article

Mar 31, 2023

Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades  (3,319 times)
Sang Heon Han, Hyeong Dong Yuk
J Urol Oncol. 2023;21(1):32-44.

Original Article

Mar 31, 2023

The Landscape of Epidemiology in Urologic Cancers
Bladder Preservation With Transurethral Tumor Resection and Intravesical BCG Instillation in Superficial Muscle-Invasive Bladder Cancer: A 10-Year Follow-up  (3,255 times)
Dong Gyun Kim, Ji Eun Heo, Kang Su Cho, et al.
J Urol Oncol. 2023;21(1):70-78.

Original Article

Mar 31, 2023

Optimal Management of Bacillus Calmette-Guérin–Refractory Non–Muscle-Invasive Bladder Cancer in 2023  (3,127 times)
Jiwoong Yu, Hyun Hwan Sung
J Urol Oncol. 2023;21(3):228-240.

Invited Review

Nov 30, 2023

Optimal Management for BCG Unresponsive Non-Muscle-Invasive Bladder Cancer
Poorer Outcomes in Bladder Cancer Patients With Diabetes: A Systematic Review and Meta-analysis Addressing Over 226,472 Bladder Cancer Patients  (3,121 times)
Stefani Frost, Parisa Ziarati, Ryan Moen, et al.
J Urol Oncol. 2024;22(1):78-94.

Systemic Review and Meta-analysis

Mar 31, 2024

Bladder Cancer
The Current State and Future of Plasma Cell-Free DNA Analysis in Urologic Malignancies  (3,060 times)
Shusuke Akamatsu, Kei Mizuno, Takayuki Sumiyoshi, et al.
J Urol Oncol. 2023;21(1):23-31.

Review Article

Mar 31, 2023

Genetic Testing for Prostate Cancer, Urothelial Cancer, and Kidney Cancer  (3,019 times)
Hyunho Han, Minyong Kang, Seok-Soo Byun, et al.
J Urol Oncol. 2023;21(2):128-139.

Invited Review

Jul 31, 2023

Genetic Testing and Nonsurgical Management for Renal Cell Carcinoma
Radical Cystectomy Versus Bladder-Preserving Therapy in Muscle-Invasive Bladder Cancer Patients After Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Analysis  (2,884 times)
Youngheun Jo, Jun Seok Kim, Yoo Sub Shin, et al.
J Urol Oncol. 2023;21(2):165-173.

Original Article

Jul 31, 2023

Trimodality Therapy and Immuno-Oncology for Bladder Cancer
The Prognostic Impact of Angiolymphatic Invasion in Bladder Urothelial Carcinoma Patients Undergoing Radical Cystectomy  (2,883 times)
Jin Hyuck Kim, Young Hwii Ko, Jong Wook Kim, et al.
J Urol Oncol. 2023;21(1):79-87.

Original Article

Mar 31, 2023

Role of Radiotherapy in Metastatic Renal Cell Carcinomas: An Evolutionary Journey in a Misunderstood Histological Type  (2,832 times)
Chan Woo Wee, Jaeho Cho
J Urol Oncol. 2023;21(3):217-227.

Invited Review

Nov 30, 2023

Perioperative Considerations and Treatment for Advanced Renal Cell Carcinoma
The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials  (2,657 times)
Sang Hun Song, Jong Jin Oh
J Urol Oncol. 2023;21(2):154-164.

Invited Review

Jul 31, 2023

Trimodality Therapy and Immuno-Oncology for Bladder Cancer
The Role of Magnetic Resonance Imaging (MRI) and MRI-Targeted Biopsy for Active Surveillance  (2,499 times)
Chang Wook Jeong
J Urol Oncol. 2023;21(2):97-105.

Invited Review

Jul 31, 2023

mpMRI in the Management of Prostate Cancer: Role, Limitation, and Cost-Effectiveness
Contemporary Management of Small Renal Masses by Urologic Oncologists: A 2022 Korean Renal Cancer Study Group Practice Pattern Survey  (2,491 times)
Joongwon Choi, Cheryn Song, Jungyo Suh, et al.
J Urol Oncol. 2023;21(1):59-69.

Original Article

Mar 31, 2023

Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use  (2,478 times)
Byung Kwan Park
J Urol Oncol. 2023;21(2):106-111.

Invited Review

Jul 31, 2023

mpMRI in the Management of Prostate Cancer: Role, Limitation, and Cost-Effectiveness
Bladder Cancer in South Korea: Analysis of Trends and Risk Factors of Bladder Cancer in South Korea Using a Nationwide Database  (2,472 times)
Sangjun Yoo, Kyung-Do Han, Kwang Taek Kim, et al.
J Urol Oncol. 2023;21(1):45-52.

Original Article

Mar 31, 2023

A Cost-Benefit Comparison of Biparametric Magnetic Resonance Imaging Versus Conventional Prostate Cancer Screening  (2,423 times)
Jung Sik Huh, Kyung Kgi Park
J Urol Oncol. 2023;21(2):121-127.

Original Article

Jul 31, 2023

mpMRI in the Management of Prostate Cancer: Role, Limitation, and Cost-Effectiveness
Summarizing the Intentions and Outcomes of Journal of Urologic Oncology 2024 Issue 2  (2,351 times)
Cheol Kwak
J Urol Oncol. 2024;22(2):97-99.

Editorial

Jul 31, 2024

Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review  (2,345 times)
Chang Wook Jeong
J Urol Oncol. 2024;22(1):4-10.

Invited Review

Mar 31, 2024

Prostate Cancer
Influence of Body Composition on the Perioperative and Survival Outcomes of Renal Cell Carcinoma  (2,276 times)
Edouard H. Nicaise, Benjamin N. Schmeusser, Yash B. Shah, et al.
J Urol Oncol. 2023;21(3):183-199.

Invited Review

Nov 30, 2023

Perioperative Considerations and Treatment for Advanced Renal Cell Carcinoma
Korean Urologic Oncology Society Guidelines: Does Angioembolization Improve the Quality of Life for Renal Cell Carcinoma Patients With Intractable Symptoms Who Are Unfit for Surgery?  (2,261 times)
Ja Yoon Ku, Hui Mo Gu, Seong Hyeon Yu, et al.
J Urol Oncol. 2023;21(2):140-147.

Invited Review

Jul 31, 2023

Genetic Testing and Nonsurgical Management for Renal Cell Carcinoma
The Future of Adjuvant Therapy in Renal Cell Carcinoma: Recent Insights and Prospects  (2,257 times)
Hyerim Ha, Joo Han Lim
J Urol Oncol. 2023;21(3):208-216.

Invited Review

Nov 30, 2023

Perioperative Considerations and Treatment for Advanced Renal Cell Carcinoma
The Use of 5-Alpha Reductase Inhibitors Improves the Detection of Prostate Cancer by Increasing Opportunities for Repeated Prostate-Specific Antigen Testing: A Decade-Long (2007–2016) Nationwide Observational Study in Korea  (2,190 times)
Young Hwii Ko, Sang Won Kim, Hoseob Kim, et al.
J Urol Oncol. 2023;21(1):53-58.

Original Article

Mar 31, 2023

Efficacy of Partial Nephrectomy in the Management of Unpredicted pT3a Renal Cell Carcinoma  (2,178 times)
Dongsu Kim, Bumjin Lim, Jungyo Suh, et al.
J Urol Oncol. 2023;21(2):148-153.

Original Article

Jul 31, 2023

Genetic Testing and Nonsurgical Management for Renal Cell Carcinoma
Nephron-Sparing Surgery for Upper Urinary Tract Urothelial Carcinoma  (2,154 times)
Sung Han Kim, Ilma S. Savul, Seth P. Lerner
J Urol Oncol. 2024;22(1):68-77.

Invited Review

Mar 31, 2024

Bladder Cancer
Preoperative Renal Artery Embolization Before Radical Nephrectomy for Nonmetastatic Renal Cell Carcinoma: A Propensity Score Matched Analysis  (2,103 times)
Jin Noh, Sang Hun Song, Gyoohwan Jung, et al.
J Urol Oncol. 2023;21(3):200-207.

Topic Article

Nov 30, 2023

Perioperative Considerations and Treatment for Advanced Renal Cell Carcinoma
Predictive Factors of Abiraterone Response in Patients With High-Risk Metastatic Hormone-Sensitive Prostate Cancer  (2,098 times)
Jaeyoung Cho, Jungyo Suh, Dalsan You, et al.
J Urol Oncol. 2023;21(3):257-263.

Topic Article

Nov 30, 2023

Clinical Predictors of ARTA Response in Metastatic Prostate Cancer
Impact of Multiparametric Magnetic Resonance Imaging for the Prediction of Extraprostatic Extension According to the National Comprehensive Cancer Network Risk Stratification in Prostate Cancer  (2,088 times)
Jae Hoon Kang, Jun-Koo Kang, Jae-Wook Chung, et al.
J Urol Oncol. 2023;21(2):112-120.

Topic Article

Jul 31, 2023

mpMRI in the Management of Prostate Cancer: Role, Limitation, and Cost-Effectiveness
Multidisciplinary Team Approach in Prostate-Specific Membrane Antigen Theranostics for Prostate Cancer: A Narrative Review  (2,022 times)
Minseok Suh, Gi Jeong Cheon
J Urol Oncol. 2024;22(1):11-20.

Invited Review

Mar 31, 2024

Prostate Cancer
Clinical Outcomes of Patients With Variant Histology of Urothelial Carcinoma After Radical Cystectomy  (1,971 times)
Dan Bee Lee, Jae Yeon Kim, Yun Ha Lee, et al.
J Urol Oncol. 2023;21(3):249-256.Correction in: 2024;22(2):183

Original Article

Nov 30, 2023

Optimal Management for BCG Unresponsive Non-Muscle-Invasive Bladder Cancer

Journal of
Urologic Oncology

Print ISSN: 2951-603X
Online ISSN: 2982-7043


Editorial Office
Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine,
101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
TEL: +82-2-2072-0817,   FAX: +82-2-742-4665   Email: journal@e-juo.org
Korean Urological Oncology Society
50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Tel: +82-2-704-8574, E-mail: leeseh@yuhs.ac

Copyright © The Korean Urological Oncology Society.

Developed in M2PI